Labor Rights

Showing 682 articles
Business

Starz Entertainment: The Bull Case for a Streaming Underdog

Following a sharp post-spinoff rally and subsequent pullback, Starz Entertainment (STRZ) is drawing value investors with its deep discount, niche content strategy, and a restructuring plan aimed at sustainable cash flow. Activist stakes and potential M&A add further intrigue to the story.

Business

MasTec's Growth Engine Faces a Cost Test: Can Margins Hold the Line?

Despite a stellar share price run, MasTec's earnings quality is under scrutiny as persistent margin pressures from supply chain strains and strategic growth investments challenge its financial resilience. Investors are watching to see if management can steer the infrastructure giant toward more sustainable profitability.

Business

Gilead Sciences Bets on Precision Oncology to Power Next Growth Phase

Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.